DK0679718T3 - Fremgangsmåde til fremstilling af alfa-interferon - Google Patents

Fremgangsmåde til fremstilling af alfa-interferon

Info

Publication number
DK0679718T3
DK0679718T3 DK95104596T DK95104596T DK0679718T3 DK 0679718 T3 DK0679718 T3 DK 0679718T3 DK 95104596 T DK95104596 T DK 95104596T DK 95104596 T DK95104596 T DK 95104596T DK 0679718 T3 DK0679718 T3 DK 0679718T3
Authority
DK
Denmark
Prior art keywords
alpha
production
alpha interferon
free
ifn
Prior art date
Application number
DK95104596T
Other languages
English (en)
Inventor
Erich Hochuli
Urs Ettlin
Alfred Schacher
Karl Weyer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK0679718T3 publication Critical patent/DK0679718T3/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B21MECHANICAL METAL-WORKING WITHOUT ESSENTIALLY REMOVING MATERIAL; PUNCHING METAL
    • B21BROLLING OF METAL
    • B21B13/00Metal-rolling stands, i.e. an assembly composed of a stand frame, rolls, and accessories
    • B21B13/06Metal-rolling stands, i.e. an assembly composed of a stand frame, rolls, and accessories with axes of rolls arranged vertically, e.g. edgers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK95104596T 1994-04-09 1995-03-29 Fremgangsmåde til fremstilling af alfa-interferon DK0679718T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94105532 1994-04-09

Publications (1)

Publication Number Publication Date
DK0679718T3 true DK0679718T3 (da) 2001-10-22

Family

ID=8215847

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95104596T DK0679718T3 (da) 1994-04-09 1995-03-29 Fremgangsmåde til fremstilling af alfa-interferon

Country Status (7)

Country Link
US (1) US6005075A (da)
EP (2) EP0679718B1 (da)
JP (1) JP2859162B2 (da)
AT (1) ATE205256T1 (da)
DE (1) DE69522492T2 (da)
DK (1) DK0679718T3 (da)
ES (1) ES2161793T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW491855B (en) * 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
SK287372B6 (sk) * 1998-11-12 2010-08-09 Schering Corporation Spôsob zvýšenia výťažku prostriedku obsahujúceho interferón-alfa
EP1140144A4 (en) * 1998-12-31 2002-10-30 Viragen Inc METHODS AND COMPOSITION OF EXTREMELY PURIFIED NATURAL MIXTURES OF TYPE I INTERFERONS DERIVED FROM LEUCOCYTES
EP1268514B1 (en) * 2000-03-27 2006-06-07 Genetics Institute, LLC Methods for purifying highly anionic proteins
DK1404428T3 (da) * 2001-06-05 2006-10-30 Genetics Inst Llc Fremgangsmåder til oprensning af stærkt anioniske proteiner
ITBO20010426A1 (it) 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
ITMI20012345A1 (it) * 2001-11-08 2003-05-08 Internat Ct For Genetic En Gin Procedimento per la produzione di interferone alfa di grado terapeutico
AU2002304965A1 (en) 2002-05-24 2003-12-12 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
US20060018875A1 (en) * 2004-06-14 2006-01-26 Blatt Lawrence M Interferon compositions and methods of use thereof
JP5944101B2 (ja) * 2008-01-18 2016-07-05 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 非グリコシル化タンパク質の精製
SG172386A1 (en) 2008-12-23 2011-08-29 Schering Corp Purification of recombinantly produced interferon
DE102010046817A1 (de) * 2010-09-28 2012-03-29 Sartorius Stedim Biotech Gmbh Verfahren zur Abtrennung von Viren aus einem Kontaminanten enthaltenden flüssigen Medium
CN114671944A (zh) * 2022-04-29 2022-06-28 江苏尤里卡生物科技有限公司 一种人绒毛膜促性腺激素纯化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651308A5 (de) * 1980-07-01 1985-09-13 Hoffmann La Roche Interferone und deren herstellung.
US4485038A (en) * 1982-10-19 1984-11-27 Health Research (Roswell Park Division) Method for the production and purification of human leukocyte interferon
US4620948A (en) * 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
CA1231306A (en) * 1983-03-03 1988-01-12 Erich Hochuli Purification of interferon
AU598455B2 (en) * 1984-12-27 1990-06-28 Suntory Limited Method for purifying an interferon
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
JPS6411640A (en) * 1987-07-02 1989-01-17 Engelhard Nippon Precious metal adsorbent
MX9102512A (es) * 1990-12-14 1992-06-01 Schering Corp Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon.
AU648214B2 (en) * 1991-12-31 1994-04-14 Lucky Limited Recombinant gene coding for human alpha interferon and expression vector thereof, etc.

Also Published As

Publication number Publication date
EP0679718A2 (en) 1995-11-02
EP0679718B1 (en) 2001-09-05
ES2161793T3 (es) 2001-12-16
EP0679718A3 (en) 1996-08-21
ATE205256T1 (de) 2001-09-15
US6005075A (en) 1999-12-21
DE69522492T2 (de) 2002-05-23
EP1104809A1 (en) 2001-06-06
JP2859162B2 (ja) 1999-02-17
DE69522492D1 (de) 2001-10-11
JPH07322887A (ja) 1995-12-12

Similar Documents

Publication Publication Date Title
DK0679718T3 (da) Fremgangsmåde til fremstilling af alfa-interferon
DE69003175T2 (de) Verfahren und Vorrichtung zur Plasmaaussenabscheidung von hydroxylionenfreier Silika.
DE69031748T2 (de) Plasmabehandlung mit Metallmasken-Integration
DE59101397D1 (de) O-glycosyliertes ifn-alpha.
DE69226253T2 (de) Plasmaätzverfahren und Reaktor zur Plasmabearbeitung
HUP9802324A2 (hu) Ribavirin és alfa-interferon felhasználása hepatitis C kezelésére
DE600440T1 (de) Verfahren und Vorrichtung zur Reinigung von Abgasen.
DE69110359D1 (de) Zusammensetzung zur Reinigung von elektronischen und Präzisionsteilen und Reinigungsverfahren.
DE59103741D1 (de) Verfahren zur reduktiven Dehydrohalogenierung von Halogenkohlenwasserstoffen und Halogenethern.
ES2035668T3 (es) Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.
DE59002994D1 (de) Vorrichtung zur selektiven Elimination von Plasmabestandteilen aus Blut.
ITRM910144A1 (it) Fibra di ceramica, metallo o carbonio rivestita e procedimento diproduzione
DE59102062D1 (de) Verfahren zur biologischen Reinigung von Abluftströmen.
DE59106539D1 (de) Verfahren zur Oberflächenbehandlung von Bauteilen.
DE69011806D1 (de) Gesinterter Glas-Keramikkörper und Verfahren.
DE58905302D1 (de) Rollenherdofen zur waermebehandlung, insbesondere von kleinteilen aus metall und keramik.
DE69131657D1 (de) Verfahren zur industriellen Herstellung von 4-Chloro-3-sulfamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-Benzamid
DE69014057T2 (de) Verfahren zur Schmelzreduktion von Metallen und Schmelzreduktionsofen.
DE59500343D1 (de) Verfahren und Vorrichtung zur Aufbereitung von Lampen
DE69105823T2 (de) Verfahren zur Behandlung von Metallmatrixverbundwerkstoffen.
ATE94588T1 (de) Verfahren zur herstellung und reinigung von alpha-interferon.
DE69014501D1 (de) Verfahren zur Behandlung von Titanlegierung und damit hergestelltes Stück.
DE69112474D1 (de) Verfahren zur oberflächlichen Entionisierung von Glasbändern, Vorrichtung dafür und erhaltene entionisierte Produkte.
DE69011567D1 (de) Verfahren zur Herstellung von elektronischen und optischen Komponenten.
DE69635131D1 (de) Verwendung von beta-interferon zur behandlung der restenose